Oswald B, Shelburne F, Landis B, Linker A, Quarfordt S
Biochem Biophys Res Commun. 1986 Nov 26;141(1):158-64. doi: 10.1016/s0006-291x(86)80348-5.
The binding of Apolipoprotein E supplemented triglyceride emulsions to sulfated glycosaminoglycans demonstrated specificity for the carbohydrate polymers. Glucosamine containing glycosaminoglycans with relatively less sulfate had little affinity for the Apo E emulsion whereas those with more sulfate (i.e. heparin and sulfated heparans) effectively bound the emulsion. Galactosamine containing glycosaminoglycans (chondroitin 4 sulfate and dermatan sulfate) demonstrated no binding. The Apo E induced uptake of triglyceride emulsions by hepatocytes was inhibited by highly sulfated polysaccharides (i.e. heparin, dextran sulfate) but other glycosaminoglycans which did not bind the emulsion were ineffective in this inhibition. The same sulfated compounds which inhibited the hepatocyte Apo E emulsion interaction effectively released hepatic lipase from isolated heptic perfusions. Glycosaminoglycan sulfates which did not bind the Apo E supplemented emulsions and did not inhibit hepatocyte association were ineffective in releasing lipase. A heparan mixture isolated from human liver was much less effective in inhibiting Apo E induced association of emulsions with hepatocytes, than heparin. A highly sulfated octasaccharide fraction isolated from bovine liver heparin inhibited more effectively than the human heparans but less than the heparin. Inhibition of Apo E mediated hepatocyte emulsion association was produced by a one hour exposure of the cells to either heparinase or heparanase. The heparanase was more active than the heparinase and both were effective in the presence of protease inhibitors. Enzymes hydrolyzing chondroitin sulfates and hyaluronic acid were ineffective in inhibiting the Apo E induced association. The specific binding of human low density lipoprotein to the hepatocyte was much less effected by the heparanase exposure than the Apo E mediated binding.
载脂蛋白E补充的甘油三酯乳剂与硫酸化糖胺聚糖的结合显示出对碳水化合物聚合物的特异性。含葡萄糖胺且硫酸盐含量相对较少的糖胺聚糖对载脂蛋白E乳剂几乎没有亲和力,而硫酸盐含量较高的(即肝素和硫酸化乙酰肝素)则能有效结合该乳剂。含半乳糖胺的糖胺聚糖(硫酸软骨素4和硫酸皮肤素)未显示出结合作用。高度硫酸化的多糖(即肝素、硫酸葡聚糖)可抑制载脂蛋白E诱导的肝细胞对甘油三酯乳剂的摄取,但其他不与乳剂结合的糖胺聚糖在这种抑制作用中无效。同样,有效抑制肝细胞与载脂蛋白E乳剂相互作用的硫酸化化合物能有效从离体肝脏灌注中释放肝脂肪酶。不与载脂蛋白E补充乳剂结合且不抑制肝细胞结合的糖胺聚糖硫酸盐在释放脂肪酶方面无效。从人肝脏分离的乙酰肝素混合物在抑制载脂蛋白E诱导的乳剂与肝细胞结合方面比肝素效果差得多。从牛肝肝素中分离出的高度硫酸化的八糖组分比人乙酰肝素抑制作用更有效,但比肝素弱。细胞暴露于肝素酶或乙酰肝素酶1小时可抑制载脂蛋白E介导的肝细胞与乳剂的结合。乙酰肝素酶比肝素酶更具活性,且在存在蛋白酶抑制剂的情况下两者均有效。水解硫酸软骨素和透明质酸的酶在抑制载脂蛋白E诱导的结合方面无效。与载脂蛋白E介导的结合相比,乙酰肝素酶暴露对人低密度脂蛋白与肝细胞的特异性结合影响要小得多。